MedPath

An open randomised Comparative Study of 2 drug Vyoshadi Churna and Loha Bhasma in the Management of Pandu Roga with Special Reference to Iron Deficiency Anaemia

Phase 3
Conditions
Health Condition 1: D509- Iron deficiency anemia, unspecified
Registration Number
CTRI/2024/05/067409
Lead Sponsor
APMs Ayurved Mahavidyalaya
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients having cardinal signs of pandu roga -panduta

arohana ayasa

Pindikodweshtana

Klama with or without other lakshanas of the disease.

Haemoglobin percentage between 8- 12 g% in males and 7- 11 g% in females.

Blood picture presenting with either microcytic hypochromic or normocytic

hypochromic anaemia.

Exclusion Criteria

Pregnant women & lactating mothers.

Patients suffering from infectious diseases.

Patients who have acute or chronic blood loss.

Patients with systemic disorders that would interfere with the course of the study.

All types of secondary, congenital & hereditary anaemia.

Patients who do not give consent for treatment.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hb% <br/ ><br>RBC <br/ ><br>PCV <br/ ><br>MCV <br/ ><br>Iron study-(TIBC ,Percentage saturation ,Total iron)Timepoint: Base line and on 30th Day
Secondary Outcome Measures
NameTimeMethod
Pandutha <br/ ><br>Arohana ayasa <br/ ><br>Agni bala <br/ ><br>Aruchi <br/ ><br>Hrudaya spandanam <br/ ><br>Srama <br/ ><br>Gatra shoola <br/ ><br>Akshikoota shodha <br/ ><br>Loma shatana <br/ ><br>PindikodweshtanaTimepoint: Base line, on 10th day, 20th day and 30th day.
© Copyright 2025. All Rights Reserved by MedPath